AML with nucleoporin 98- retinoic acid receptor gamma (NUP98-RARG) is identical to APL in terms of morphology, immunophenotype, and clinical manifestations but lacks the t(15;17)(q22;q21)/PML-RARA fusion (2). Here, RARG is linked to acute myeloid leukemia.